|
Discrepancies were found with a patient's results for multiple immunocap allegen(s)/ allergen component(s).The sample was initially tested ((b)(6) 2025) on phadia 1000 instrument, serial number: (b)(6), yielding the following results: immunocap allergen f13, peanut: <0.10/ class 0.Immunocap allergen component rara h2 peanut f423: 0.09/ class 0.Immunocap allergen f23, crab: <0.10/ class 0.Immunocap allergen f202 cashew nut: <0.10/ class 0.Immunocap allergen f207, clam: <0.10/ class 0.Immunocap allergen f290, oyster: <0.10/ class 0.Immunocap allergen f338, scallop: <0.10/ class 0.The sample was repeated (10/01/2025) on alternate phadia 1000 instrument, serial no: (b)(6), the same immunocap allegen(s)/ allergen component(s) yielded the following results: immunocap allergen f13, peanut: >100/ class 6.Immunocap allergen component rara h2 peanut f423: >100/ class 6.Immunocap allergen f23, crab: 33.2/ class 4.Immunocap allergen f202, cashew nut: 21.1/ class 4.Immunocap allergen f207, clam: 13.6/ class 3.Immunocap allergen f290, oyster: 7.60/ class 3.Immunocap allergen f338, scallop: 20.9/ class 4.The repeat test results aligned more with the patient's history.Investigation is ongoing to determine possible root-cause.There is insufficient information if any adverse event has occured.
|